Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Cresco Labs Inc. (C:CL)

Business Focus: Pharmaceuticals

INK Edge Outlook

Mostly sunny as of October 01, 2020
For the latest outlook, get the company report

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for CL within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Oct 14, 2020 08:00 ET
Cresco Labs Launches Remedi Cannabis Brand Into New York
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the launch of its
Read full article
Oct 13, 2020 08:00 ET
Cresco Labs to Report Third Quarter 2020 Financial Results on November 18th, 2020
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report its financial results for the third quarter ended September 30th, 2020 on Wednesday, November 18th, 2020 before the market opens.
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
6.78
5.96
10.78
Price to Book - most recent quarter
4.38
2.60
2.96
Price to Cash Flow per share - TTM
--
10.12
11.70
Price to Free Cash Flow per share - TTM
--
15.94
20.59
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Oct 15, 2020192,881-43,803
Sep 30, 2020236,684-17,097
Sep 15, 2020253,78121,507
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Cresco Labs Inc., formerly Randsburg International Gold Corp., is a cannabis operator in United States. The Company manufactures a suite of cannabis extracts and vape products. The Company is a processor and retailer of cannabis products with operations in six states, including Illinois, Ohio, Pennsylvania, Nevada, California and Arizona. It distributes its cannabis products to dispensaries.

See business summary

 

Twitter

Search (past week) for $CL.CA